-transparent.png){kind=logo}
In order to evaluate the optimum number of doses for catch-up primary vaccination against pertussis, 248 Swedish children 3-4 years of age were randomized to receive either two or three doses of a three-component or a five-component acellular pertussis vaccine. Adverse reactions were mild, but increased with increasing number of doses, especially in a subgroup of 17 children with serological signs of earlier pertussis. There were no clinically significant differences between the two vaccines. Antibody levels against pertussis were higher after two doses in this age group than after three doses in infancy. A primary vaccination program for older children can use two instead of three doses.
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
August 1999,
Infection and immunity,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
April 1999,
Vaccine,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
September 2004,
Vaccine,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
November 2012,
Clinical and vaccine immunology : CVI,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
October 1992,
American journal of diseases of children (1960),
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
June 1999,
Vaccine,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
August 1997,
Fortschritte der Medizin,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
January 2012,
Przeglad epidemiologiczny,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
January 2016,
The new microbiologica,
O Wärngård, and
L Nilsson, and
C Fåhraeus, and
L Gustafsson, and
H O Hallander, and
P Olin, and
J Storsaeter
June 2002,
Prescrire international,
